Cyanotech

Cyanotech Corporation is a United States microalgae producer associated with cultivation and commercialization of algae-derived nutritional ingredients and branded dietary-supplement products. The company was co-founded in 1983 by Gerry Cysewski and operates on leased land at the Natural Energy Laboratory of Hawaii Authority on the Kona Coast of Hawaii Island. Its location supports the cultivation of microalgae in a tropical, high-sunlight environment and forms a central part of the company's identity and production model. Cyanotech's best-known offerings are BioAstin Natural Astaxanthin and Hawaiian Spirulina Pacifica. Astaxanthin is a naturally occurring carotenoid produced by certain microalgae, while spirulina is a nutrient-rich cyanobacterium commonly used in dietary supplements. Cyanotech presents these products as naturally sourced nutritional ingredients and branded supplements rather than as conventional pharmaceutical therapies. The company therefore sits at the intersection of biotechnology, specialty food ingredients, vitamins, and dietary supplements. A significant milestone came in 1999, when the BioAstin brand received U.S. Food and Drug Administration recognition as generally recognized as safe for a product containing astaxanthin. This regulatory development helped establish BioAstin as an early branded astaxanthin product in the U.S. supplement market. The available reference material does not provide a complete account of subsequent ownership, financial performance, executive leadership, geographic sales distribution, or product-by-product commercial history. Those details should be verified against current corporate filings and company materials before being added. Cyanotech's positioning is built around vertically connected microalgae production, Hawaiian provenance, and the conversion of algae biomass into branded nutritional products. Its principal public identity is that of a specialist producer rather than a broad consumer packaged-goods conglomerate. The company remains associated with its Hawaii cultivation base and its two core product families, although the current status and scope of individual product lines require confirmation from up-to-date official sources.

Cyanotech was co-founded in 1983 by Gerry Cysewski. From its early development, the company focused on microalgae production and the use of algae-derived materials in nutritional products. Its operating base is connected with the Natural Energy Laboratory of Hawaii Authority on the Kona Coast of Hawaii Island, where the company leases land for cultivation and related operations. The company's business model centers on producing microalgae and turning that biological output into commercial nutritional products. This distinguishes Cyanotech from supplement companies that primarily source finished ingredients from external manufacturers. The company's Hawaii setting is important both operationally and commercially: the Kona Coast provides a location suited to outdoor algae cultivation and gives the brand a distinctive geographic identity. Cyanotech's principal branded products are BioAstin Natural Astaxanthin and Hawaiian Spirulina Pacifica. BioAstin is based on natural astaxanthin, a carotenoid associated with microalgae, while Hawaiian Spirulina Pacifica is a spirulina product positioned as a source of nutritional compounds. The products place Cyanotech within the dietary-supplement and specialty-nutrition sectors rather than the pharmaceutical sector. In 1999, BioAstin became the first product containing astaxanthin to receive Food and Drug Administration recognition as generally recognized as safe, according to the cited company history. This was a notable regulatory and commercial milestone for the brand because it provided a formal U.S. safety status for the product category at a time when astaxanthin was still an emerging supplement ingredient. The supplied reference material does not document later corporate transactions, changes in control, detailed product launches, financial results, executive appointments, or the company's current distribution footprint. Consequently, Cyanotech's documented history is best characterized as the development of a Hawaii-based microalgae producer with two prominent branded nutritional product families and a significant 1999 astaxanthin regulatory milestone.

1. 1999BioAstin receives GRAS recognition

   BioAstin receives U.S. Food and Drug Administration recognition as generally recognized as safe for a product containing natural astaxanthin.

   Source
2. 1983Cyanotech is co-founded

   Gerry Cysewski co-founds Cyanotech, which develops as a producer of microalgae and algae-derived nutritional products in Hawaii.

   Source

A Hawaii-based specialist in naturally sourced microalgae nutrition, emphasizing branded astaxanthin and spirulina products.

• BioAstin Natural AstaxanthinDietary supplement and microalgae-derived astaxanthin product

  BioAstin is Cyanotech's branded natural astaxanthin offering. Astaxanthin is a carotenoid associated with certain microalgae and is used in the dietary-supplement market. The brand's documented regulatory milestone occurred in 1999, when it received U.S. Food and Drug Administration recognition as generally recognized as safe for a product containing astaxanthin. The available sources do not specify the complete current range of formats, formulations, or distribution channels.

• Hawaiian Spirulina PacificaSpirulina dietary supplement

  Hawaiian Spirulina Pacifica is Cyanotech's branded spirulina product family. It is based on cultivated spirulina, a nutrient-rich cyanobacterium used in food and dietary supplements. The name links the product to Cyanotech's Hawaiian production identity and its microalgae cultivation operations. The supplied reference does not provide a detailed launch chronology, formulation list, or current product status.

1. Cyanotech
2. Cyanotech official website